| Literature DB >> 35564800 |
Alie H D Mansaray1, Dennis P Y Yankson1, Raymonda A B Johnson1, Francis L Moses2,3, Joseph Sam Kanu4,5, Ibrahim Franklyn Kamara6, Rony Zachariah7, Ajay M V Kumar8,9,10, Kalaiselvi Selvaraj11.
Abstract
The transfer of antibiotic resistance from animals to humans is of concern in recent times. One potential source of such transfer is the untreated poultry excreta used as manure in farming. We aim to identify bacterial isolates and antibiotic susceptibility patterns of Escherichia coli in poultry excreta in Sierra Leone. This was a cross-sectional study of fresh poultry excreta samples collected from four commercial poultry sites in Freetown, Sierra Leone, from June-September 2021. Bacterial isolates were tested against eight antibiotics using established standards. Of 100 samples, 93 showed Escherichia coli (93%): of those, eight isolates also had Salmonella (8%). E. coli was 100% resistant to all three 'Watch' drugs (erythromycin, cefoxitin and streptomycin) and tetracycline. E. coli was least resistant to ampicillin (12%), followed by chloramphenicol (35%). The prevalence of multidrug resistance was 95.6%. Multiple antibiotic resistance index ranged from 0.5-0.7 (optimal < 0.2), indicating high prior exposure to antibiotics in these poultries. Such high levels of resistance in E. coli isolated from poultry excreta could pose a serious threat to humans. We recommend (i) routine surveillance to monitor antibiotic resistance in poultry excreta, (ii) using poultry excreta as manure only after treatment and (iii) restricting the use of antibiotics as prophylactics and growth promoters in poultry feeds.Entities:
Keywords: Escherichia coli; SORT IT; Sierra Leone; antimicrobial resistance; bacterial isolates; microbial sensitivity tests; one health; operational research; poultry excreta; surveillance
Mesh:
Substances:
Year: 2022 PMID: 35564800 PMCID: PMC9100810 DOI: 10.3390/ijerph19095405
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Patterns of antibiotic sensitivity for E. coli isolates of poultry excreta in Sierra Leone, 2021 (N = 93).
| Name of Antibiotic | No. of Isolates Tested for Sensitivity | Antibiogram * | |||||
|---|---|---|---|---|---|---|---|
| Sensitive | Intermediate | Resistant | |||||
|
| (%) |
| (%) |
| (%) | ||
| Ampicillin | 93 | 0 | (0) | 82 | (88) | 11 | (12) |
| Chloramphenicol | 92 | 26 | (28) | 34 | (37) | 32 | (35) |
| Erythromycin | 65 | 0 | (0) | 0 | (0) | 65 | (100) |
| Cefoxitin | 88 | 0 | (0) | 0 | (0) | 88 | (100) |
| Penicillin | 88 | 0 | (0) | 35 | (40) | 53 | (60) |
| Streptomycin | 93 | 0 | (0) | 0 | (0) | 93 | (100) |
| Sulfafurazole | 93 | 0 | (0) | 35 | (38) | 58 | (62) |
| Tetracycline | 63 | 0 | (0) | 0 | (0) | 63 | (100) |
* Susceptible/Sensitive (Susceptible; standard dosing regimen): A microorganism is categorised as “Susceptible, standard dosing regimen”, when there is a high likelihood of therapeutic success using a standard dosing regimen of the agent. Intermediate (Susceptible; increased exposure): A microorganism is categorised as “Susceptible, Increased exposure *” when there is a high likelihood of therapeutic success, because exposure to the agent is increased by adjusting the dosing regimen or by its concentration at the site of infection. Resistant: A microorganism is categorised as “Resistant” when there is a high likelihood of therapeutic failure even when there is increased exposure [31].
Phenotypic antibiotic resistance profile of E. coli isolates from poultries in Sierra Leone 2021.
| No. of Antibiotics | Phenotypic Resistance Profile | No. of Isolates | MARI |
|---|---|---|---|
| Four | AMP CHL STR SFZ | 5 | 0.50 |
| Six | AMP CHL CXT PEN STR SFZ | 20 | 0.56 |
| Seven | AMP CHL CXT PEN STR SFZ TET | 3 | 0.43 |
| AMP CHL ERY CXT PEN STR SFZ | 5 | 0.60 | |
| Eight | AMP CHL ERY CXT PEN STR SFZ TET | 60 | 0.74 |
MARI: Multi Antibiotic Resistance Index; AMP: Ampicillin; CHL: Chloramphenicol; STR: Streptomycin; SFZ: Sulfafurazole; CXT: Cefoxitin, PEN: Penicillin; TET: Tetracycline; ERY: Erythromycin.
Figure 1Antibiotic resistance disaggregated by the WHO AwaRe * classification for E. coli isolated from poultry excreta in Free Town, Sierra Leone 2021 (N = 93). * Access category: antibiotics that have activity against a wide range of commonly encountered susceptible pathogens while also showing lower resistance potential than antibiotics in the other groups. Watch category: This group includes antibiotics that have higher resistance potential and includes most of the highest priority agents among the “Critically Important Antimicrobials for Human Medicine” and/or antibiotics that are at relatively high risk of selection of bacterial resistance [28].
Figure 2Antibiotic resistance disaggregated by WHO Critically important * classification for E. coli isolated from poultry excreta in Free Town, Sierra Leone 2021 (N = 93). Critically Important: Antibiotics fulfilling both of these following criteria: 1. Antibiotics that were the sole limited therapeutic choice to treat life-threatening bacterial infections; 2. Antibiotics used to treat infections caused by bacteria from non-human sources or with resistance genes from non-human sources. Highly Important: Antibiotics fulfilling only one of the following criteria: 1. Antibiotics which were the sole limited therapeutic choice to treat life-threatening bacterial infections; 2. Antibiotics used to treat infections caused by bacteria from non-human sources or with resistance genes from non-human sources [27].